FL CARES: Cancer Drug Property Dataset

Brand Name:
Code(s): LGX818
Approved:
Kinase Class: S/T
Inhibitor Type: ?
Literature (PubMed): <a href="https://pubchem.ncbi.nlm.nih.gov/compound/#section=Literature" target="_blank"> 0
Target(s): B-Raf proto-oncogene, serine/threonine kinase
Disease(s): Colorectal cancer , melanoma , non-small-cell lung carcinoma

Encorafenib US FDA Label

Compound: methyl N-[(2S)-1-[[4-[3-[5-chloro-2-fluoro-3-(methanesulfonamido)phenyl]-1-propan-2-ylpyrazol-4-yl]pyrimidin-2-yl]amino]propan-2-yl]carbamate
Description: NA

International Nonproprietary Name: ENCORAFENIB [INN] (Source: PubChem)

KEGG Drug ID: D11053 (Source: PubChem)

USFDA Precision ID: UNII-8L7891MRB6 (Source: PubChem)

US Adopted Name: ENCORAFENIB [USAN] (Source: PubChem)

Sources: PubChem (4)